These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 21868534)
21. Aberrant methylation of the CHFR gene in digestive tract cancer. Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A Anticancer Res; 2006; 26(3A):1791-5. PubMed ID: 16827108 [TBL] [Abstract][Full Text] [Related]
22. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa. Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187 [TBL] [Abstract][Full Text] [Related]
23. Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas. Ebert MP; Model F; Mooney S; Hale K; Lograsso J; Tonnes-Priddy L; Hoffmann J; Csepregi A; Röcken C; Molnar B; Schulz HU; Malfertheiner P; Lofton-Day C Gastroenterology; 2006 Nov; 131(5):1418-30. PubMed ID: 17101318 [TBL] [Abstract][Full Text] [Related]
24. Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival. Maeda K; Kawakami K; Ishida Y; Ishiguro K; Omura K; Watanabe G Oncol Rep; 2003; 10(4):935-8. PubMed ID: 12792748 [TBL] [Abstract][Full Text] [Related]
25. Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer. Hibi K; Sakata M; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y Anticancer Res; 2008; 28(3A):1581-4. PubMed ID: 18630515 [TBL] [Abstract][Full Text] [Related]
26. Lymph node metastasis is infrequent in patients with highly-methylated colorectal cancer. Hibi K; Nakao A Anticancer Res; 2006; 26(1A):55-8. PubMed ID: 16475679 [TBL] [Abstract][Full Text] [Related]
27. Frequent CDH3 demethylation in advanced gastric carcinoma. Hibi K; Kitamura YH; Mizukami H; Goto T; Sakuraba K; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y Anticancer Res; 2009 Oct; 29(10):3945-7. PubMed ID: 19846933 [TBL] [Abstract][Full Text] [Related]
28. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer. Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486 [TBL] [Abstract][Full Text] [Related]
30. Downregulation of EphA7 by hypermethylation in colorectal cancer. Wang J; Kataoka H; Suzuki M; Sato N; Nakamura R; Tao H; Maruyama K; Isogaki J; Kanaoka S; Ihara M; Tanaka M; Kanamori M; Nakamura T; Shinmura K; Sugimura H Oncogene; 2005 Aug; 24(36):5637-47. PubMed ID: 16007213 [TBL] [Abstract][Full Text] [Related]
31. p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patients. Hibi K; Mizukami H; Saito M; Kigawa G; Nemoto H Hepatogastroenterology; 2014; 61(130):354-6. PubMed ID: 24901139 [TBL] [Abstract][Full Text] [Related]
32. Methylation of TFPI2 no longer detected in the serum DNA of colorectal cancer patients after curative surgery. Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y Anticancer Res; 2012 Mar; 32(3):787-90. PubMed ID: 22399594 [TBL] [Abstract][Full Text] [Related]
33. Detection of TFPI2 methylation in the serum of gastric cancer patients. Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y Anticancer Res; 2011 Nov; 31(11):3835-8. PubMed ID: 22110206 [TBL] [Abstract][Full Text] [Related]
34. CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer. Kim HC; Roh SA; Ga IH; Kim JS; Yu CS; Kim JC J Gastroenterol Hepatol; 2005 Dec; 20(12):1920-6. PubMed ID: 16336454 [TBL] [Abstract][Full Text] [Related]
35. Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. Miotto E; Sabbioni S; Veronese A; Calin GA; Gullini S; Liboni A; Gramantieri L; Bolondi L; Ferrazzi E; Gafà R; Lanza G; Negrini M Cancer Res; 2004 Nov; 64(22):8156-9. PubMed ID: 15548679 [TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of the MYOD1 gene is a novel prognostic factor in patients with colorectal cancer. Hiranuma C; Kawakami K; Oyama K; Ota N; Omura K; Watanabe G Int J Mol Med; 2004 Mar; 13(3):413-7. PubMed ID: 14767572 [TBL] [Abstract][Full Text] [Related]
37. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker. Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997 [TBL] [Abstract][Full Text] [Related]
38. Detailed methylation patterns and protein expression profiles of MGMT in colorectal carcinoma surgical margins. Zhang D; Bai Y; Wang Y; Luo J; Ge Q; Qiao Y; Jia C; Lu Z Clin Biochem; 2008 Jan; 41(1-2):19-25. PubMed ID: 18028895 [TBL] [Abstract][Full Text] [Related]
39. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152 [TBL] [Abstract][Full Text] [Related]